Biocraft cephalosporin plant
Executive Summary
Firm is renovating a 42,000 square foot facility in Fairfield, New Jersey for use as a cephalosporin manufacturing plant. Biocraft said it hopes to obtain FDA approval for the plant as well as an unspecified number of cephalosporin applications by the fall. The company does not yet market any cephalosporins